Scientific & Regulatory Consulting•Toxicology & Product Safety
Request basket0
PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Dicobalt Edetate→

Dicobalt Edetate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
36499-65-7
Molecular formula
C10H12Co2N2O8
Molecular weight
406.08 g/mol
Drug class
Cobalt-based cyanide antidotecyanide complexation agent
Mechanism of action
Dicobalt edetate provides cobalt ions that bind cyanide to form a stable cobalt-cyanide complex, reducing free cyanide available to inhibit cytochrome c oxidase. Because unbound cobalt can cause severe cardiovascular toxicity, use is restricted to severe cyanide poisoning when the diagnosis is sufficiently certain.
Indications / reported uses
  • Emergency antidote for severe, confirmed or strongly suspected cyanide poisoning in jurisdictions where dicobalt edetate remains authorised; it is not suitable for empiric use when cyanide exposure is uncertain.

Sources: https://www.ema.europa.eu/en/documents/scientific-discussion/cyanokit-epar-scientific-discussion_en.pdf · https://pubmed.ncbi.nlm.nih.gov/ · FDA product information

View request basketPrefer email? [email protected]
PDE / ADE derivationOEL derivationOEB / OHC bandingRequest basket0
Substance information

Drug class, mechanism of action and general use cases

Drug class

Cobalt-based cyanide antidote; cyanide complexation agent

Mechanism of action

Dicobalt edetate provides cobalt ions that bind cyanide to form a stable cobalt-cyanide complex, reducing free cyanide available to inhibit cytochrome c oxidase. Because unbound cobalt can cause severe cardiovascular toxicity, use is restricted to severe cyanide poisoning when the diagnosis is sufficiently certain.

General use cases

  • Emergency antidote for severe, confirmed or strongly suspected cyanide poisoning in jurisdictions where dicobalt edetate remains authorised; it is not suitable for empiric use when cyanide exposure is uncertain.

For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.

Assessment scope

Project-specific PDE/ADE and OEL/OEB support

Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.

  • PDE/ADE: critical effects, point of departure and justified adjustment factors.
  • OEL: inhalation hazards, exposure duration and workplace conditions.
  • OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
  • Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope

PDE/ADE and OEL/OEB assessment

ReguSight provides project-specific support for Dicobalt Edetate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Dicobalt Edetate Permitted Daily Exposure (PDE) report (the Dicobalt Edetate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Dicobalt Edetate Occupational Exposure Limit (OEL) report (the Dicobalt Edetate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.